Lv4
790 积分 2022-11-06 加入
Tolerability of hypertonic injectables
7个月前
已完结
Cancer Statistics
8个月前
已完结
Cancer statistics
8个月前
已关闭
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
8个月前
已完结
Cross-resistance and drug sequence in prostate cancer
8个月前
已完结
Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
8个月前
已完结
Prostate cancer in Asia: A collaborative report
8个月前
已完结
Prostate cancer in China: epidemiological trends, genomic insights, and future directions for optimized management
8个月前
已完结
Cancer incidence and mortality in China, 2022
8个月前
已完结
MIRD pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry--standardization of nomenclature
8个月前
已完结
皖公网安备34019202002308
